LYPHE Group | Medical cannabis health tech for patient access

Access and care. LYPHE is UK's most popular cannabis clinical telehealth and dispensing ecosystem. We own the medical cannabis supply chain vertically from digital clinical care, manufacturing medical cannabis, to pharmacy home delivery direct-to-patients.

Our pursuit is for patient access to be mainstream and global.

Cannabis units despatched

+

Patient consultations

+

UK market share

%+

Digital platforms (telehealth, dispensing, education)

x

Own label medical cannabis brand

No.

Healthcare professionals trained

+

Cannabis Prescription Dispensing

Order, track and manage your medical prescriptions here.

Telehealth Cannabis Care

Clinical services carried out via video consultations.

Educating Cannabis Doctors

Advanced medical cannabis training online.

Cannabinoids
for the endocannabinoid system

Medical cannabis applications for our ecosystem and beyond.

13 August 2021

LYPHE Group co-founders Dean Friday and Jonathan Nadler talk to Business of Cannabis about UK and European cannabis markets, and the recent expansion into Switzerland

Interviews

LYPHE Group announces new Medical Advisory Board to assist with Unique Cannabis Healthtech & Research Solutions

5 August 2021

LYPHE Group announces new Medical Advisory Board to assist with Unique Cannabis Healthtech & Research Solutions

Lyphe Group

Visit the newsroom

Proud to stock the best medical cannabis brands in the world:

UK's No.1 Medical Cannabis Group

+

+

%+

x

No.

+

Cannabis Prescription Dispensing

Telehealth Cannabis Care

Educating Cannabis Doctors

Cannabinoidsfor the endocannabinoid system

Subscribe to our newsletter

Cannabinoids
for the endocannabinoid system